PuraPharm Corporation Limited (1498.HK)

HKD 0.5

(-1.0%)

Operating Expenses Summary of PuraPharm Corporation Limited

  • PuraPharm Corporation Limited's latest annual operating expenses in 2023 was 216.62 Million HKD , down -18.04% from previous year.
  • PuraPharm Corporation Limited's latest quarterly operating expenses in 2024 Q2 was 120.24 Million HKD , down -12.09% from previous quarter.
  • PuraPharm Corporation Limited reported a annual operating expenses of 325.08 Million HKD in annual operating expenses 2022, down -19.58% from previous year.
  • PuraPharm Corporation Limited reported a annual operating expenses of 404.23 Million HKD in annual operating expenses 2021, up 8.21% from previous year.
  • PuraPharm Corporation Limited reported a quarterly operating expenses of 129.63 Million HKD for 2023 Q2, down -21.75% from previous quarter.
  • PuraPharm Corporation Limited reported a quarterly operating expenses of 266.42 Million HKD for 2023 FY, down -18.04% from previous quarter.

Annual Operating Expenses Chart of PuraPharm Corporation Limited (2023 - 2013)

Historical Annual Operating Expenses of PuraPharm Corporation Limited (2023 - 2013)

Year Operating Expenses Operating Expenses Growth
2023 216.62 Million HKD -18.04%
2022 325.08 Million HKD -19.58%
2021 404.23 Million HKD 8.21%
2020 373.56 Million HKD -18.58%
2019 458.83 Million HKD 12.76%
2018 406.92 Million HKD 10.24%
2017 369.11 Million HKD 22.42%
2016 301.51 Million HKD 17.69%
2015 256.18 Million HKD 44.39%
2014 177.43 Million HKD 0.45%
2013 176.63 Million HKD 0.0%

Peer Operating Expenses Comparison of PuraPharm Corporation Limited

Name Operating Expenses Operating Expenses Difference
Pak Fah Yeow International Limited 24.42 Million HKD -786.951%
Grand Pharmaceutical Group Limited 3.86 Billion HKD 94.389%
Extrawell Pharmaceutical Holdings Limited 35.52 Million HKD -509.759%
Wai Yuen Tong Medicine Holdings Limited 353.93 Million HKD 38.794%
Qianhai Health Holdings Limited 17.1 Million HKD -1166.688%
Lee's Pharmaceutical Holdings Limited 590.99 Million HKD 63.345%
Essex Bio-Technology Limited 1.22 Billion HKD 82.373%
Tongfang Kontafarma Holdings Limited 503.46 Million HKD 56.972%
SSY Group Limited 1.98 Billion HKD 89.063%
JBM (Healthcare) Limited 163.87 Million HKD -32.191%
Jacobson Pharma Corporation Limited 287.34 Million HKD 24.611%
China Resources Pharmaceutical Group Limited 29.35 Billion HKD 99.262%